Search
Statistics
We have 222 registered usersThe newest registered user is raheelmemon
Our users have posted a total of 1140 messages in 613 subjects
If you are seeing this, you have attempted to link to the UpToDate widget but are experiencing a problem. Please visit UpToDate for more information.
Guide to State-by-State Opioid Prescribing Policies
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Guide to State-by-State Opioid Prescribing Policies
Guide to State-by-State Opioid Prescribing Policies
Physicians and others involved with prescribing controlled substances must be well-versed in the legal requirements including knowledge of both federal and state law. The Controlled Substances Act (CSA) is the federal law that regulates such substances. The CSA is a rather complete and functional law and provides an operational framework the prescriber should understand. The Drug Enforcement Administration (DEA) publishes a guide for prescribers entitled "Practitioner's Manual, an Informational Outline of the Controlled Substances Act." This resource provides a comprehensive overview of the Controlled Substances Act and the federal requirements for prescribing controlled substances.
Additionally, all states have further regulations involving controlled substances. The physician should be aware that state laws often impose additional, stricter requirements on prescribing controlled substances. Physicians must be aware of these regulations to practice lawfully within their local jurisdiction and in compliance with State Board of Medicine regulations.
Click Here for Details: Guide to State-by-State Opioid Prescribing Policies
Similar topics
» FDA has Approved Tapentadol (Nucynta): an Extended-Release Oral Opioid
» ‘Boxed in’ or ‘boxed out’? Prescribing Atypicals For Dementia
» Evaluation of the FDA Warning Against Prescribing Citalopram at Doses Exceeding 40 mg
» Quiz Time: Opioid Relapse Prevention
» Second-Generation Antiepileptic Drugs and Pregnancy: A Guide For Clinicians.
» ‘Boxed in’ or ‘boxed out’? Prescribing Atypicals For Dementia
» Evaluation of the FDA Warning Against Prescribing Citalopram at Doses Exceeding 40 mg
» Quiz Time: Opioid Relapse Prevention
» Second-Generation Antiepileptic Drugs and Pregnancy: A Guide For Clinicians.
FORUM FOR PSYCHIATRY RESIDENTS :: Psychiatry :: Psychiatry-Neurology-Psychology discussion :: Psycho-Pharmacology
Page 1 of 1
Permissions in this forum:
You cannot reply to topics in this forum
Sat Sep 10, 2016 1:45 pm by Admin
» L-Methylfolate: Who Will benefit
Sat Sep 03, 2016 3:00 pm by Admin
» Vitamins & Supplements in Clinical Practice.
Sun Aug 21, 2016 12:27 pm by Admin
» Imaging Biomarkers for Outcomes in Mild TBI
Fri Jul 22, 2016 12:37 pm by Admin
» Q.5 Clozapine Neutopenia
Mon Jul 11, 2016 8:43 pm by Admin
» Treating Disorders!
Mon Jul 04, 2016 1:52 am by troymackys
» Cortical Abnormalities in Adults & Adolescents with MDD
Sun Jul 03, 2016 12:59 pm by Admin
» Efficacy of Antipsychotics in Pediatric Acute Mania
Wed Jun 22, 2016 8:46 pm by Admin
» Obsessive Compulsive Disorder in Adults: Which Treatment is Better?
Tue Jun 21, 2016 9:34 pm by Admin